Balchem Corporation
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment… Read more
Balchem Corporation (BCPC) - Net Assets
Latest net assets as of December 2025: $1.26 Billion USD
Based on the latest financial reports, Balchem Corporation (BCPC) has net assets worth $1.26 Billion USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.71 Billion) and total liabilities ($450.15 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.26 Billion |
| % of Total Assets | 73.64% |
| Annual Growth Rate | 17.79% |
| 5-Year Change | 43.37% |
| 10-Year Change | 141.33% |
| Growth Volatility | 7.5 |
Balchem Corporation - Net Assets Trend (1985–2025)
This chart illustrates how Balchem Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Balchem Corporation (1985–2025)
The table below shows the annual net assets of Balchem Corporation from 1985 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $1.26 Billion | +9.35% |
| 2024-12-31 | $1.15 Billion | +9.10% |
| 2023-12-31 | $1.05 Billion | +12.33% |
| 2022-12-31 | $938.28 Million | +6.99% |
| 2021-12-31 | $877.01 Million | +5.89% |
| 2020-12-31 | $828.23 Million | +11.37% |
| 2019-12-31 | $743.67 Million | +7.53% |
| 2018-12-31 | $691.62 Million | +12.12% |
| 2017-12-31 | $616.88 Million | +18.40% |
| 2016-12-31 | $521.03 Million | +12.36% |
| 2015-12-31 | $463.70 Million | +18.32% |
| 2014-12-31 | $391.90 Million | +18.27% |
| 2013-12-31 | $331.36 Million | +21.37% |
| 2012-12-31 | $273.01 Million | +17.67% |
| 2011-12-31 | $232.01 Million | +23.76% |
| 2010-12-31 | $187.47 Million | +27.40% |
| 2009-12-31 | $147.14 Million | +28.50% |
| 2008-12-31 | $114.51 Million | +23.02% |
| 2007-12-31 | $93.08 Million | +23.51% |
| 2006-12-31 | $75.36 Million | +23.68% |
| 2005-12-31 | $60.93 Million | +21.30% |
| 2004-12-31 | $50.23 Million | +26.28% |
| 2003-12-31 | $39.78 Million | +19.57% |
| 2002-12-31 | $33.27 Million | +31.33% |
| 2001-12-31 | $25.33 Million | +29.38% |
| 2000-12-31 | $19.58 Million | +9.39% |
| 1999-12-31 | $17.90 Million | +13.29% |
| 1998-12-31 | $15.80 Million | +28.46% |
| 1997-12-31 | $12.30 Million | +30.85% |
| 1996-12-31 | $9.40 Million | +27.03% |
| 1995-12-31 | $7.40 Million | +25.42% |
| 1994-12-31 | $5.90 Million | +15.69% |
| 1993-12-31 | $5.10 Million | +13.33% |
| 1992-12-31 | $4.50 Million | +2.27% |
| 1991-12-31 | $4.40 Million | +18.92% |
| 1990-12-31 | $3.70 Million | +19.35% |
| 1989-12-31 | $3.10 Million | +10.71% |
| 1988-12-31 | $2.80 Million | +16.67% |
| 1987-12-31 | $2.40 Million | +14.29% |
| 1986-12-31 | $2.10 Million | +16.67% |
| 1985-12-31 | $1.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Balchem Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1121296.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.12 Billion | 89.18% |
| Common Stock | $2.14 Million | 0.17% |
| Other Comprehensive Income | $41.55 Million | 3.30% |
| Other Components | $92.33 Million | 7.34% |
| Total Equity | $1.26 Billion | 100.00% |
Balchem Corporation Competitors by Market Cap
The table below lists competitors of Balchem Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Pidilite Industries Limited
NSE:PIDILITIND
|
$5.36 Billion |
|
Enphase Energy Inc
NASDAQ:ENPH
|
$5.36 Billion |
|
Porsche Automobil Holding SE
PINK:POAHF
|
$5.36 Billion |
|
Altair Engineering Inc
NASDAQ:ALTR
|
$5.36 Billion |
|
Grupo Aeroportuario del Centro Norte SAB de CV
NASDAQ:OMAB
|
$5.35 Billion |
|
International Games System Co Ltd
TWO:3293
|
$5.35 Billion |
|
Grifols S.A
PINK:GIFLF
|
$5.35 Billion |
|
United Bankshares Inc
NASDAQ:UBSI
|
$5.35 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Balchem Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,149,913,000 to 1,257,413,000, a change of 107,500,000 (9.3%).
- Net income of 154,845,000 contributed positively to equity growth.
- Dividend payments of 28,287,000 reduced retained earnings.
- Share repurchases of 107,636,000 reduced equity.
- Other comprehensive income increased equity by 65,294,000.
- Other factors increased equity by 23,284,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $154.84 Million | +12.31% |
| Dividends Paid | $28.29 Million | -2.25% |
| Share Repurchases | $107.64 Million | -8.56% |
| Other Comprehensive Income | $65.29 Million | +5.19% |
| Other Changes | $23.28 Million | +1.85% |
| Total Change | $- | 9.35% |
Book Value vs Market Value Analysis
This analysis compares Balchem Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.37x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 2101.32x to 4.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $0.08 | $168.36 | x |
| 1986-12-31 | $0.08 | $168.36 | x |
| 1987-12-31 | $0.09 | $168.36 | x |
| 1988-12-31 | $0.12 | $168.36 | x |
| 1989-12-31 | $0.14 | $168.36 | x |
| 1990-12-31 | $0.17 | $168.36 | x |
| 1991-12-31 | $0.18 | $168.36 | x |
| 1992-12-31 | $0.18 | $168.36 | x |
| 1993-12-31 | $0.22 | $168.36 | x |
| 1994-12-31 | $0.26 | $168.36 | x |
| 1995-12-31 | $0.30 | $168.36 | x |
| 1996-12-31 | $0.40 | $168.36 | x |
| 1997-12-31 | $0.50 | $168.36 | x |
| 1998-12-31 | $0.62 | $168.36 | x |
| 1999-12-31 | $0.72 | $168.36 | x |
| 2000-12-31 | $0.81 | $168.36 | x |
| 2001-12-31 | $1.03 | $168.36 | x |
| 2002-12-31 | $1.33 | $168.36 | x |
| 2003-12-31 | $1.57 | $168.36 | x |
| 2004-12-31 | $1.92 | $168.36 | x |
| 2005-12-31 | $2.26 | $168.36 | x |
| 2006-12-31 | $2.74 | $168.36 | x |
| 2007-12-31 | $3.35 | $168.36 | x |
| 2008-12-31 | $4.01 | $168.36 | x |
| 2009-12-31 | $5.10 | $168.36 | x |
| 2010-12-31 | $6.33 | $168.36 | x |
| 2011-12-31 | $7.67 | $168.36 | x |
| 2012-12-31 | $8.99 | $168.36 | x |
| 2013-12-31 | $10.74 | $168.36 | x |
| 2014-12-31 | $12.57 | $168.36 | x |
| 2015-12-31 | $14.66 | $168.36 | x |
| 2016-12-31 | $16.32 | $168.36 | x |
| 2017-12-31 | $19.14 | $168.36 | x |
| 2018-12-31 | $21.32 | $168.36 | x |
| 2019-12-31 | $22.88 | $168.36 | x |
| 2020-12-31 | $25.48 | $168.36 | x |
| 2021-12-31 | $26.84 | $168.36 | x |
| 2022-12-31 | $28.97 | $168.36 | x |
| 2023-12-31 | $32.48 | $168.36 | x |
| 2024-12-31 | $35.15 | $168.36 | x |
| 2025-12-31 | $38.57 | $168.36 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Balchem Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.31%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.93%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.36x
- Recent ROE (12.31%) is below the historical average (15.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 22.22% | 7.69% | 1.44x | 2.00x | $220.00K |
| 1986 | 14.29% | 5.17% | 1.53x | 1.81x | $90.00K |
| 1987 | 16.67% | 5.88% | 1.42x | 2.00x | $160.00K |
| 1988 | 14.29% | 4.76% | 1.45x | 2.07x | $120.00K |
| 1989 | 9.68% | 3.13% | 1.75x | 1.77x | $-10.00K |
| 1990 | 16.22% | 5.56% | 1.80x | 1.62x | $230.00K |
| 1991 | 18.18% | 6.30% | 1.67x | 1.73x | $360.00K |
| 1992 | 4.44% | 1.57% | 1.67x | 1.69x | $-250.00K |
| 1993 | 11.76% | 4.08% | 1.60x | 1.80x | $90.00K |
| 1994 | 13.56% | 4.23% | 1.54x | 2.08x | $210.00K |
| 1995 | 21.62% | 6.40% | 1.75x | 1.93x | $860.00K |
| 1996 | 20.21% | 7.20% | 1.75x | 1.61x | $960.00K |
| 1997 | 22.76% | 9.79% | 1.63x | 1.43x | $1.57 Million |
| 1998 | 18.99% | 10.45% | 1.27x | 1.43x | $1.42 Million |
| 1999 | 17.32% | 10.44% | 1.35x | 1.23x | $1.31 Million |
| 2000 | 19.04% | 11.23% | 1.43x | 1.19x | $1.77 Million |
| 2001 | 20.17% | 11.07% | 1.04x | 1.76x | $2.58 Million |
| 2002 | 22.29% | 12.32% | 1.13x | 1.60x | $4.09 Million |
| 2003 | 14.17% | 9.11% | 1.09x | 1.43x | $1.66 Million |
| 2004 | 15.98% | 11.91% | 1.12x | 1.20x | $3.00 Million |
| 2005 | 17.98% | 1.31% | 11.17x | 1.23x | $4.86 Million |
| 2006 | 16.29% | 12.17% | 1.09x | 1.23x | $4.74 Million |
| 2007 | 17.32% | 9.15% | 1.14x | 1.66x | $6.81 Million |
| 2008 | 16.64% | 8.21% | 1.50x | 1.35x | $7.60 Million |
| 2009 | 18.20% | 12.21% | 1.17x | 1.28x | $12.07 Million |
| 2010 | 17.75% | 13.05% | 1.12x | 1.22x | $14.53 Million |
| 2011 | 16.71% | 13.28% | 1.07x | 1.17x | $15.56 Million |
| 2012 | 14.65% | 12.89% | 0.99x | 1.14x | $12.70 Million |
| 2013 | 13.54% | 13.31% | 0.89x | 1.14x | $11.74 Million |
| 2014 | 13.48% | 9.76% | 0.63x | 2.20x | $13.64 Million |
| 2015 | 12.88% | 10.81% | 0.63x | 1.90x | $13.35 Million |
| 2016 | 10.74% | 10.12% | 0.58x | 1.82x | $3.87 Million |
| 2017 | 14.60% | 15.14% | 0.62x | 1.56x | $28.38 Million |
| 2018 | 11.36% | 12.21% | 0.66x | 1.42x | $9.41 Million |
| 2019 | 10.71% | 12.38% | 0.56x | 1.55x | $5.30 Million |
| 2020 | 10.22% | 12.03% | 0.60x | 1.41x | $1.80 Million |
| 2021 | 10.96% | 12.03% | 0.67x | 1.37x | $8.40 Million |
| 2022 | 11.23% | 11.18% | 0.58x | 1.73x | $11.54 Million |
| 2023 | 10.30% | 11.77% | 0.58x | 1.52x | $3.14 Million |
| 2024 | 11.17% | 13.47% | 0.61x | 1.37x | $13.48 Million |
| 2025 | 12.31% | 14.93% | 0.61x | 1.36x | $29.10 Million |
Industry Comparison
This section compares Balchem Corporation's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $6,152,730,030
- Average return on equity (ROE) among peers: 7.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Balchem Corporation (BCPC) | $1.26 Billion | 22.22% | 0.36x | $5.36 Billion |
| AirBoss of America Corp (ABSSF) | $125.98 Million | 8.11% | 0.98x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $35.57 Million | 18.14% | 0.12x | $0.99 |
| Aimia Inc (AIMFF) | $-294.90 Million | 0.00% | 0.00x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $5.54 Billion | 13.10% | 0.99x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $5.64 Billion | 14.71% | 1.46x | $9.73 Billion |
| Albemarle Corp (ALB) | $4.47 Billion | 8.41% | 1.34x | $19.07 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $45.06 Billion | 14.66% | 1.28x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $68.56 Million | -5.13% | 0.13x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $795.40 Million | 0.08% | 0.51x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $94.90 Million | -0.82% | 1.54x | $212.84 Million |